Innovent Biologics, Inc. (HKG: 1801)
Hong Kong
· Delayed Price · Currency is HKD 31.05
-0.40 (-1.27%)
Jan 20, 2025, 4:08 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 50.86 billion as of January 17, 2025. Its market cap has decreased by -22.47% in one year.
Market Cap
50.86B
Enterprise Value
45.19B
Revenue
8.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
31.05
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 50.86B, an increase of 174.37%. That is a compound annual growth rate of 17.59%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 174.25B |
| Hansoh Pharmaceutical Group Company | 99.93B |
| JD Health International | 90.36B |
| WuXi Biologics | 73.58B |
| Sinopharm Group | 63.66B |
| Alibaba Health Information Technology | 53.23B |
| Akeso | 53.09B |
| Sino Biopharmaceutical | 52.92B |